Silk Road Medical, Inc

NASDAQ:SILK

27.49 (USD) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2023202220212020201920182017
Revenue 177.134138.638101.47575.22763.35434.55714.258
Cost of Revenue 50.04837.87625.44621.29115.92710.8745.129
Gross Profit 127.086100.76276.02953.93647.42723.6839.129
Gross Profit Ratio 0.7170.7270.7490.7170.7490.6850.64
Reseach & Development Expenses 41.32436.44927.1121.27112.27210.2587.242
General & Administrative Expenses 144.572115.9796.16675.3362.85834.8220.261
Selling & Marketing Expenses 0.4610.3470.2210.1940.3620.1860.218
SG&A 145.033116.31796.38775.52463.2234.8220.261
Other Expenses 0.442-0.19-0.023-0.08-21.054-12.0632.927
Operating Expenses 186.357152.766123.49796.79575.49245.07827.503
Operating Income -59.271-52.004-47.468-42.859-28.065-21.395-18.374
Operating Income Ratio -0.335-0.375-0.468-0.57-0.443-0.619-1.289
Total Other Income Expenses Net 3.528-3.006-2.343-4.506-24.35-12.0632.927
Income Before Tax -55.743-55.01-49.811-47.365-52.415-37.63-19.356
Income Before Tax Ratio -0.315-0.397-0.491-0.63-0.827-1.089-1.358
Income Tax Expense 0.0433.0060.5763.023.658-11.8746.87
Net Income -55.743-58.016-50.387-50.385-56.073-37.629-19.356
Net Income Ratio -0.315-0.418-0.497-0.67-0.885-1.089-1.358
EPS -1.44-1.62-1.45-1.53-2.44-1.31-0.8
EPS Diluted -1.44-1.62-1.45-1.53-2.44-1.31-0.8
EBITDA -55.479-49.667-47.293-41.755-26.409-32.752-15.284
EBITDA Ratio -0.313-0.358-0.466-0.555-0.417-0.948-1.072